{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-007223","form_type":"8-K","ticker":"GLSI","cik":"0001799788","company_name":"Greenwich LifeSciences, Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.573362+00:00","generated_at":"2026-06-05T23:17:29.922862+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Greenwich LifeSciences dismisses MaloneBailey; engages RBSM as new auditor","bullets":["Audit committee approved dismissal of MaloneBailey and engagement of RBSM on Feb 14, 2024.","MaloneBailey informed of dismissal effective Feb 15, 2024; RBSM engaged for FY 2023 audit.","MaloneBailey's reports for 2021-2022 had no adverse opinion, disclaimer, or qualification.","No disagreements on accounting or audit scope during 2022-2023 or through Feb 14, 2024.","Material weaknesses in internal control over financial reporting were previously disclosed and discussed with both auditors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-007223","json":"https://secwatch.observer/filing/0001493152-24-007223.json","markdown":"https://secwatch.observer/filing/0001493152-24-007223.md","text":"https://secwatch.observer/filing/0001493152-24-007223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/0001493152-24-007223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:17:29.922862+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"80c9681ef2b0cd860efcc706806b03e12e94ee6d","claim":"Greenwich LifeSciences, Inc. dismissed MaloneBailey LLP as its auditor.","evidence_excerpt":"On February 14, 2024, the audit committee of the Board of Directors of Greenwich LifeSciences, Inc. (the “Company”) approved the dismissal of MaloneBailey LLP (“Malone”) as the Company’s independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/0001493152-24-007223-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"MaloneBailey LLP"},{"label":"Successor","value":"RBSM LLP"}],"fact_type":"auditor_change"},{"claim_id":"eb1d1001dace272a081954c61f61a703f807c57a","claim":"Greenwich LifeSciences, Inc. engaged RBSM LLP as its auditor.","evidence_excerpt":"approved the engagement of RBSM LLP (“RBSM”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ended December 31, 2023","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/0001493152-24-007223-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"RBSM LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}